학술논문
Hematooncology: Zanubrutinib is the new therapeutic standard in relapsed/refractory chronic lymphocytic leukemia
Document Type
Article
Author
Source
In: Arzneimitteltherapie . (Arzneimitteltherapie, May 2023, 41(5):125-126)
Subject
Language
English
German
German
ISSN
07236913